Edwards Lifesciences (Brazil) Performance
| E1WL34 Stock | 103.20 2.90 2.89% |
Edwards Lifesciences has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.57, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Edwards Lifesciences are expected to decrease at a much lower rate. During the bear market, Edwards Lifesciences is likely to outperform the market. Edwards Lifesciences right now shows a risk of 1.9%. Please confirm Edwards Lifesciences maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Edwards Lifesciences will be following its price patterns.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Edwards Lifesciences may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 1.2 B | |
| Total Cashflows From Investing Activities | -1.7 B | |
| Free Cash Flow | 1.4 B |
Edwards |
Edwards Lifesciences Relative Risk vs. Return Landscape
If you would invest 9,413 in Edwards Lifesciences on August 24, 2024 and sell it today you would earn a total of 907.00 from holding Edwards Lifesciences or generate 9.64% return on investment over 90 days. Edwards Lifesciences is generating 0.1638% of daily returns and assumes 1.9039% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Edwards, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Edwards Lifesciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Edwards Lifesciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Edwards Lifesciences, and traders can use it to determine the average amount a Edwards Lifesciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | E1WL34 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.9 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Edwards Lifesciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.
Edwards Lifesciences Fundamentals Growth
Edwards Stock prices reflect investors' perceptions of the future prospects and financial health of Edwards Lifesciences, and Edwards Lifesciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Edwards Stock performance.
| Return On Equity | 0.26 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 243.98 B | |||
| Shares Outstanding | 618.26 M | |||
| Price To Book | 1.89 X | |||
| Price To Sales | 44.79 X | |||
| Revenue | 5.23 B | |||
| EBITDA | 1.86 B | |||
| Total Debt | 595.7 M | |||
| Book Value Per Share | 2.37 X | |||
| Cash Flow From Operations | 1.73 B | |||
| Earnings Per Share | 12.51 X | |||
| Total Asset | 8.5 B | |||
About Edwards Lifesciences Performance
By analyzing Edwards Lifesciences' fundamental ratios, stakeholders can gain valuable insights into Edwards Lifesciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Edwards Lifesciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Edwards Lifesciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Edwards Lifesciences performance evaluation
Checking the ongoing alerts about Edwards Lifesciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Edwards Lifesciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Edwards Lifesciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Edwards Lifesciences' stock performance include:- Analyzing Edwards Lifesciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Edwards Lifesciences' stock is overvalued or undervalued compared to its peers.
- Examining Edwards Lifesciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Edwards Lifesciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Edwards Lifesciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Edwards Lifesciences' stock. These opinions can provide insight into Edwards Lifesciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |